These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Characterization and significance of urinary fibrin degradation products. Cortes P; Potter EV; Kwaan HC J Lab Clin Med; 1973 Sep; 82(3):377-89. PubMed ID: 4199524 [No Abstract] [Full Text] [Related]
15. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. Cade R; Mars D; Privette M; Thompson R; Croker B; Peterson J; Campbell K Arch Intern Med; 1986 Apr; 146(4):737-41. PubMed ID: 3963956 [TBL] [Abstract][Full Text] [Related]
16. Consensus statement on management of steroid sensitive nephrotic syndrome. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics Indian Pediatr; 2001 Sep; 38(9):975-86. PubMed ID: 11568373 [No Abstract] [Full Text] [Related]
17. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome. Matsumoto K; Kanmatsuse K Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311 [TBL] [Abstract][Full Text] [Related]
18. [Cytostatic treatment of the steroid-resistant nephrotic syndrome. (Long term study on 24 patients)]. Oechslen D; Kluthe R; Sarre H Arch Klin Med; 1968; 215(2):150-60. PubMed ID: 5718136 [No Abstract] [Full Text] [Related]
20. T cell subsets in glomerulonephritis. Lin CY; Yang YM; Fu YK Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]